News
Eli Lilly's orforglipron could have a few advantages over a pill from Novo Nordisk, including a lack of dietary restrictions ...
"Losing weight is a choice. But it should never be made because of society’s aesthetic obsession with thinness." ...
This is all you need to know about the new weight loss jab 'Reta' that's said to be 3 times stronger than Ozempic.
Telehealth company Ro has tapped tennis star Serena Williams as a celebrity patient ambassador for its weight-loss treatments ...
Tennis legend Serena Williams is sharing her journey with weight loss drugs, saying she's lost 31 pounds in 8 months using GLP-1s.
After years of GLP-1 ads spotlighting anonymous bellies and dancing commercial actors, telehealth firm Ro is ushering in weight-loss drugs’ celebrity-endorsement era.
Before Novo arrived as its owner, issues at the Bloomington facility caused a two-month delay for Eylea HD’s FDA approval ...
3d
MedPage Today on MSNGood News on GLP-1s and Cancer Risk, With One Exception
With follow-up ranging from 1 to 11 years, use of GLP-1 agonists, such as semaglutide (Ozempic, Wegovy) and tirzepatide ...
New pill orforglipron was associated with a significant reduction in body weight and better cholesterol, triglycerides and blood pressure.
Makers of weight-loss drugs are expected to rake in more than $150 billion in revenue by the early 2030s, thanks to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results